U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07242612) titled 'Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis' on Nov. 17.
Brief Summary: This study investigates the use of blood tests known as Bone Turnover Markers (BTMs) to quickly monitor the effectiveness of osteoporosis treatment in postmenopausal women. Osteoporosis, which weakens bones and increases fracture risk, is typically monitored using a DEXA scan to measure bone density (BMD), but this method changes slowly. BTMs may show a response to medication within just 3 to 6 months. In this randomized controlled trial, 40 postmenopausal women with osteoporosis will be assigned to receive either antiresorptive d...